Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms
The Journal of Immunology (2010) - Comment
pubmed: 20421646  doi: 10.4049/jimmunol.1000045  issn: 1550-6606  issn: 0022-1767 

Martin V. Kolev, Marieta M. Ruseva, B. Paul Morgan, Rossen M. Donev